BioTillion
Private Company
Funding information not available
Overview
BioTillion is a private company, founded in 2020, that provides specialized hardware and software solutions for sample inventory management in biobanking. Its technology platform leverages RFID to enable in-situ, real-time tracking of samples stored in -80°C freezers, addressing critical pain points like sample loss, misidentification, and workflow inefficiency. The company is funded through NIH SBIR grants (Phase II/IIb) and private investors, positioning it in the growing market for biobank automation and data integrity. While its initial description suggested an AI focus for drug delivery, current public materials emphasize physical sample tracking as its core business.
Technology Platform
RFID-based hardware and software platform for real-time, in-situ tracking and inventory management of biological samples in ultra-low temperature (ULT) freezers. Includes devices for box-level mapping (BoxMapper), freezer-wide tracking (ColdSIGHT), and single-vial reading.
Opportunities
Risk Factors
Competitive Landscape
BioTillion competes in the niche market for ULT freezer sample tracking. Competitors include other RFID-specialty firms, providers of barcode-based systems (which require visual line-of-sight), and large laboratory informatics or automation companies that may offer broader inventory management suites. Its key differentiation is the ability to map boxes without removing them from the cold environment.